Understanding Your Positron Emission Tomography (PET) Scan Denial
PET scans are widely used in oncology and some neurologic and cardiac conditions, but insurers frequently deny them as not medically necessary, outside of policy indications, or unnecessary compared with CT alone.
Common Reasons for Denial
- ! PET not on policy list for this cancer type or stage
- ! Alternative imaging considered sufficient
- ! Repeat PET within restricted time window
- ! Non-oncologic use considered experimental
How We Help
We help explain how PET results will affect treatment decisions, show that your situation matches guideline-based indications, and address concerns about repeated or off-label use.
Some Types of Evidence We Can Use For Supporting Your Appeal
✓ PET imaging improves staging accuracy in many cancers, which can change surgical and systemic treatment decisions.
✓ PET scans are useful in assessing metabolic response to therapy and detecting residual or recurrent disease.
✓ Guidelines specify indications where PET is preferred or recommended over conventional imaging alone.
Frequently Asked Questions
Ready to Fight Your Positron Emission Tomography (PET) Scan Denial?
Our free AI-powered tool will help you generate a compelling appeal letter in minutes.
Disclaimer: Fight Health Insurance is not affiliated with, endorsed by, or partnered with any pharmaceutical manufacturer, healthcare provider, medical device company, or patient assistance program. All information provided is for educational and informational purposes only and does not constitute medical or legal advice. Please consult with your healthcare provider regarding treatment options and with your insurance company regarding coverage decisions.